Christoph Koellerer

Hugstetter Str. 55
Freiburg, BW 79106, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

A novel role for transcription factor NFE2 in redox regulation and chemotherapy resistance in acute myeloid leukemia.

A novel role for transcription factor NFE2 in redox regulation and chemotherapy resistance in acute myeloid leukemia.

Journal: Leukemia

Published: February 23, 2026

From image to insight: optimized multiplex staining panel for formalin-fixed, paraffin-embedded mouse bone marrow enables spatial profiling of the hematopoietic niche.

From image to insight: optimized multiplex staining panel for formalin-fixed, paraffin-embedded mouse bone marrow enables spatial profiling of the hematopoietic niche.

Journal: Experimental hematology

Published: January 15, 2026

NFE2 Truncation Mutants Protect Wild-Type NFE2 from ITCH-Dependent Degradation.

NFE2 Truncation Mutants Protect Wild-Type NFE2 from ITCH-Dependent Degradation.

Journal: International journal of molecular sciences

Published: November 10, 2025

Lysine-specific demethylase 1 regulates hematopoietic stem cell expansion and myeloid cell differentiation.

Lysine-specific demethylase 1 regulates hematopoietic stem cell expansion and myeloid cell differentiation.

Journal: Cell death & disease

Published: June 12, 2025

Oncogene-induced TIM-3 ligand expression dictates susceptibility to anti-TIM-3 therapy in mice.

Oncogene-induced TIM-3 ligand expression dictates susceptibility to anti-TIM-3 therapy in mice.

Journal: The Journal of clinical investigation

Published: November 08, 2023

The histone demethylase JMJD2C constitutes a novel NFE2 target gene that is required for the survival of JAK2V617F mutated cells.

The histone demethylase JMJD2C constitutes a novel NFE2 target gene that is required for the survival of JAK2V617F mutated cells.

Journal: Leukemia

Published: September 23, 2022

The transcription factor NFE2 enhances expression of the hematopoietic master regulators SCL/TAL1 and GATA2.

The transcription factor NFE2 enhances expression of the hematopoietic master regulators SCL/TAL1 and GATA2.

Journal: Experimental hematology

Published: June 09, 2020

Enhanced expression of the sphingosine-1-phosphate-receptor-3 causes acute myelogenous leukemia in mice.

Enhanced expression of the sphingosine-1-phosphate-receptor-3 causes acute myelogenous leukemia in mice.

Journal: Leukemia

Published: November 21, 2018

Altered NFE2 activity predisposes to leukemic transformation and myelosarcoma with AML-specific aberrations.

Altered NFE2 activity predisposes to leukemic transformation and myelosarcoma with AML-specific aberrations.

Journal: Blood

Published: September 13, 2018

Epigenetic regulation of NFE2 overexpression in myeloproliferative neoplasms.

Epigenetic regulation of NFE2 overexpression in myeloproliferative neoplasms.

Journal: Blood

Published: October 18, 2017

Showing 1-10 of 10

Last Updated: 09/26/2026